Great Bay Software

Great Bay Bio (GBB) is an AI-driven biotechnology company headquartered in Hong Kong that focuses on revolutionizing bioprocessing and drug development. The company utilizes its proprietary AI platforms, including AlfaMedX for culture media optimization and Klone4.0 for high-yield cell line development, to significantly accelerate CMC (Chemistry, Manufacturing, and Controls) timelines. GBB also maintains an internal pipeline of therapeutic candidates and collaborates with partners to develop antibodies and fusion proteins for indications in fibrosis, ophthalmology, and metabolic disorders. By integrating artificial intelligence, big data, and automation, Great Bay Bio aims to reduce the time and cost of biologics development while increasing success rates.